biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Bidding war?

<< Previous

Bullboard Posts

Next >>

Comment by chrispion Feb 24, 2022 10:03pm

138 Views

Post# 34460341

RE:RE:RE:RE:RE:Bidding war?

Chrispi, if DNLI even thought that BTI could advance their programs than we would be them!
We are pocket change to them! They could even take a "flyer" in hopes it works! And they wouldn't even notice the loss if it didn't work out!
That's seems to be a regular issue here!
Keep it real and you guys are just so off base!
You make zero sense!

beenthere, your ignorance is showing thru in spades with that clearly-lacking-thought post.
JD has already stated (and probably more than once) why Denali would never take us over, basically it would be admitting there are problems with their BBB technology and they were hedging their bets or wanted a solution that worked. Do you think they want to do that with still having a multi-billion $ market cap and a lot of high priced execs and employees that would be impacted by such an admission? We are not a complementary technology to Denali, we are a competing technology. Just because they have the funds to buy us (for multiples of our current share price) doesn't mean it makes sense for them to do so.

You want to rethink your post again? perhaps after you've done some serious thinking about it? perhaps like a serious investor who has done their DD?

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!